Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

554 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection.
Perelló C, Carrión JA, Ruiz-Antorán B, Crespo J, Turnes J, Llaneras J, Lens S, Delgado M, García-Samaniego J, García-Paredes F, Fernández I, Morillas RM, Rincón D, Porres JC, Prieto M, Lázaro Ríos M, Fernández-Rodríguez C, Hermo JA, Rodríguez M, Herrero JI, Ruiz P, Fernández JR, Macías M, Pascasio JM, Moreno JM, Serra MÁ, Arenas J, Real Y, Jorquera F, Calleja JL; Spanish Collaborative Group for the Study of the Use of Hepatitis C Direct-Acting Drugs. Perelló C, et al. Among authors: fernandez rodriguez c, fernandez jr, fernandez i. J Viral Hepat. 2017 Mar;24(3):226-237. doi: 10.1111/jvh.12637. Epub 2016 Dec 15. J Viral Hepat. 2017. PMID: 27976491
Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.
Castells L, Rimola A, Manzardo C, Valdivieso A, Montero JL, Barcena R, Abradelo M, Xiol X, Aguilera V, Salcedo M, Rodriguez M, Bernal C, Suarez F, Antela A, Olivares S, Del Campo S, Laguno M, Fernandez JR, de la Rosa G, Agüero F, Perez I, González-García J, Esteban-Mur JI, Miro JM; FIPSE LT-HIV Investigators. Castells L, et al. Among authors: fernandez jr. J Hepatol. 2015 Jan;62(1):92-100. doi: 10.1016/j.jhep.2014.07.034. Epub 2014 Aug 13. J Hepatol. 2015. PMID: 25127748
Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J. Testillano M, et al. Among authors: fernandez jr. Transplant Proc. 2009 Apr;41(3):1041-3. doi: 10.1016/j.transproceed.2009.02.030. Transplant Proc. 2009. PMID: 19376421
Long-Term Outcomes of Liver Transplantation in Patients With Pretransplant Renal Dysfunction Treated With Induction Therapy and Delayed Reduced De Novo Once-Daily Tacrolimus.
Gastaca M, Prieto M, Palomares I, Bustamante J, Fernandez JR, Ruiz P, Ventoso A, Salvador P, Senosiain M, Testillano M, Suarez MJ, Valdivieso A. Gastaca M, et al. Among authors: fernandez jr. Transplant Proc. 2020 Jun;52(5):1489-1492. doi: 10.1016/j.transproceed.2020.01.083. Epub 2020 Mar 24. Transplant Proc. 2020. PMID: 32217015
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study.
Manzardo C, Londoño MC, Castells L, Testillano M, Luis Montero J, Peñafiel J, Subirana M, Moreno A, Aguilera V, Luisa González-Diéguez M, Calvo-Pulido J, Xiol X, Salcedo M, Cuervas-Mons V, Manuel Sousa J, Suarez F, Serrano T, Ignacio Herrero J, Jiménez M, Fernandez JR, Giménez C, Del Campo S, Esteban-Mur JI, Crespo G, Moreno A, de la Rosa G, Rimola A, Miro JM; FIPSE LT-HIV investigators. Manzardo C, et al. Among authors: fernandez jr. Am J Transplant. 2018 Oct;18(10):2513-2522. doi: 10.1111/ajt.14996. Epub 2018 Aug 13. Am J Transplant. 2018. PMID: 29963780 Free article.
Early tacrolimus exposure does not impact long-term outcomes after liver transplantation.
Gastaca M, Ruiz P, Bustamante J, Martinez-Indart L, Ventoso A, Fernandez JR, Palomares I, Prieto M, Testillano M, Salvador P, Senosiain M, Suárez MJ, Valdivieso A. Gastaca M, et al. Among authors: fernandez jr. World J Hepatol. 2021 Mar 27;13(3):362-374. doi: 10.4254/wjh.v13.i3.362. World J Hepatol. 2021. PMID: 33815678 Free PMC article.
Prevalence and progression of chronic kidney disease after liver transplant: a prospective, real-life, observational, two-year multicenter study.
Herrero JI, Cuervas-Mons V, Gómez-Bravo MÁ, Fabregat J, Otero A, Bilbao I, Salcedo MM, González-Diéguez ML, Fernández JR, Serrano MT, Jiménez M, Rodrigo JM, Narváez I, Sánchez G. Herrero JI, et al. Among authors: fernandez jr. Rev Esp Enferm Dig. 2018 Sep;110(9):538-543. doi: 10.17235/reed.2018.5431/2017. Rev Esp Enferm Dig. 2018. PMID: 29893577 Free article.
Does the transjugular intrahepatic portosystemic influence the outcome of liver transplantation?
Valdivieso A, Ventoso A, Gastaca M, Bustamante J, Aguinaga A, Ruiz P, Gonzalez-Uriarte J, Martínez-Indart L, Testillano M, Fernández JR, Muñoz F, Montejo M, Matarranz A, Suárez MJ, Ortiz de Urbina J. Valdivieso A, et al. Among authors: fernandez jr. Transplant Proc. 2012 Jul-Aug;44(6):1505-7. doi: 10.1016/j.transproceed.2012.05.070. Transplant Proc. 2012. PMID: 22841197 No abstract available.
554 results